NCT06335030

Sensory and Behavioral Aspects With Particular Attention to Food Selectivity in Children With Autism

Relationship Between Sensory and Behavioral Aspects With Particular Attention to Food Selectivity in Children With Autism Spectrum Disorder and Parental Stress Perceived
IRCCS Fondazione Stella Maris·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Autism Spectrum Disorder
Study type
Observational
Sponsor & location
Primary sponsor
IRCCS Fondazione Stella Maris
Location
Pisa,Rovereto,Verona, Italy
Timeline & enrollment
Phase
N/A
Start date
Mar 29, 2021
End date
Nov 30, 2024
Enrollment
50 participants
Primary outcome

Child Oral and Motor Proficiency Scale (ChOMPS),Brief Autism Mealtime Behavior Inventory (BAMBI),Sensory Profile 2 (SP2),Child Behavior Checklist (CBCL),Parenting Stress Index (PSI),Observation of child meal-time,Food Diary,Gastrointestinal severity symptom index (GSSI),Mac Arthur

Summary

Brief Summary: Eating problems and in particular food selectivity is a condition that worsens
 a long-life disorder such as Autism Spectrum Disorder (ASD) , both on an individual level,
 both on family and social ones .
 
 Children (2-6 years) diagnosed with ASD according to Diagnostic and Statistical Manual of
 Mental Disorders 5 Edition (DSM5) criteria were enrolled in an observational, cross-sectional
 and multicentric study conducted by three different Italian clinical centers. Regarding this
 sample, principal aims of the study are to describe characteristics of food selectivity, to
 evaluate its correlation with ASD symptoms, with cognitive and adaptive functioning of ASD
 preschoolers, to describe its impact on parental stress.

ICD-10 classifications
Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06335030
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06335030 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Fondazione Stella Maris and is currently Recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.